Neither AOD 9604 nor retatrutide holds a Marketing Authorisation from the MHRA, meaning selling or supplying them with therapeutic claims in the UK is illegal under the Human Medicines Regulations 2012
Evidence suggests that GLP-1RAs do not directly prevent gout attacks, but are effective in managing cardiometabolic conditions commonly associated with gout and other arthritides
In other words, the cards are stacked against you unless you have a plan
But many people on GLP-1 medications experience a significant change in their bowel habits without meeting that clinical threshold
In a widely cited study, scientists reported that MOTS-c targets muscle tissue and helps regulate metabolism, which is why it is studied for glucose handling and insulin sensitivity (Cell Metabolism research summarized by the National Institutes of Health)
Notably, orientin reduced fibrosis, inflammatory responses, and cardiomyocyte apoptosis